Correction to ‘Pharmacovigilance study of INSTIs associated with weight gain and glucose/lipid metabolism adverse events based on the FDA adverse event reporting system’.

HOME
>
論文・技術情報
>
Correction to ‘Pharmacovigilance study of INSTIs associated with weight gain and glucose/lipid metabolism adverse events based on the FDA adverse event reporting system’.

CzeekV インデックス活用事例・実践,研究報告など、お役立ち情報をシェアします

アブストラクト
ジャーナル名	HIV medicine
Pubmed追加日	2026/6/27
投稿者
組織名
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/42362390/